REG - Croda International - Director/PDMR Shareholding

Croda InternationalAnnouncement

30/03/2020 09:55

RNS Number : 0209I
  
Croda International PLC
  
30 March 2020
  
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them



1 
 


Details of the person discharging managerial responsibilities / person closely associated 
 




a) 
 


Name 
 
 


Mrs Yootha Jane Arnott




2 
 


Reason for the notification 
 




a) 
 


Position/status 
 


PCA of PDMR (Mr Stuart Arnott)




b) 
 


Initial notification /Amendment 
 


 
Initial Notification




3 
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 
 




a) 
 


Name 
 


Croda International Plc




b) 
 


LEI 
 


2138004WCNBFJEEOXV26




4 
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 
 




a) 
 


Description of the financial instrument, type of instrument 
 
Identification code 
 


 
Ordinary Shares of 10.609756p each  
 
ISIN: GB00BJFFLV09




b) 
 


Nature of the transaction 
 


1)


Sale of shares as detailed in c) below.
 




2)


Purchase of shares as detailed in c) below.
 




3)


Transfer of shares into an ISA as detailed in c) below.
 




c) 
 


Price(s) and volume(s) 
 
 
 
 


 



Price(s)


Volume(s)




1)


4200p  


436




2)


4208.84p


436




3)


Nil


436








d) 
 


Aggregated information 
 
 
- Aggregated volume 
 
- Price 


 



Aggregated volume


Aggregated Price




1)


436


£18,312.00




2)


436


£18,350.54




3)


436


Nil








e) 
 


Date of the transaction 
 
 


2020-03-27
 




f) 
 


Place of the transaction 
 
 


XLON



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHVBLBXBXLZBBV